| Acquired by | SuperGen |
| Price | $55M |
| Date | 4/11 |
| Terms | Cash and Stock |
| Website | astex-therapeutic... |
| Category | BioTech |
| Phone | +44 (0)1223 226200 |
| info@astex-therap... | |
| Employees |
Astex is a UK-based biotechnology company that discovers and develops novel small molecule therapeutics. Using its pioneering fragment-based drug discovery platform, Pyramidâ„¢, Astex has built a pipeline of molecularly-targeted oncology drugs, of which three are currently being tested in clinical trials with others in discovery and pre-clinical development.
In addition to its proprietary research programs, Astex’s productivity in lead discovery has been endorsed through numerous partnerships with major pharmaceutical companies, including AstraZeneca, GlaxoSmithKline, Johnson & Johnson and Novartis.
